ArticleBMC infectious diseases2026
Association of pre-culture antimicrobial therapy with culture positivity in patients with vertebral osteomyelitis: a 16-year cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of Culture Status on Outcomes in Vertebral Osteomyelitis: A Retrospective Cohort Study of 206 Patients.Global spine journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicrobiological diagnosis is crucial for managing vertebral osteomyelitis (VO), but the impact of pre-culture antimicrobial therapy on culture positivity remains debated. This study aimed to investigate the association between pre-culture antimicrobial administration and the positivity of comprehensive culture tests in patients with VO.
methodsThis single-center cohort study included adult patients who were diagnosed with VO and admitted to a university hospital in Japan between 2006 and 2021. The primary outcome was the proportion of positive culture tests (blood, bone, or abscess). Pre-culture antimicrobial therapy was defined as receiving at least one systemic dose within two days before the first culture specimen collection. To adjust for confounding factors, we used the inverse probability of treatment weighting to estimate average treatment effects (ATEs) and 95% confidence intervals (CIs).
resultsOf the 133 patients, 46 (34.6%) received pre-culture antimicrobials. Overall, 65.4% of patients had at least one positive culture. Pre-culture antimicrobial therapy was significantly associated with a lower proportion of any positive culture (ATE − 0.22; 95% CI, -0.39 to -0.05). When analyzed by specimen type, significant negative associations were found for blood cultures (ATE − 0.30; 95% CI, -0.48 to -0.12) and abscess cultures (ATE − 0.33; 95% CI, -0.51 to -0.14). However, no significant association was observed for bone cultures (ATE − 0.07; 95% CI, -0.33 to 0.20). The duration of antimicrobial therapy before culture collection was not significantly associated with culture positivity.
conclusionPre-culture antimicrobial therapy was associated with a 20% to 30% lower absolute proportion of positive blood and abscess cultures but did not significantly affect the positivity of bone cultures in patients with VO. Bone biopsies may remain a valuable diagnostic tool even if antimicrobial agents have been administered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.